Skip to main content

Table 1 Results of cell count

From: In vitro inhibition of HUVECs by low dose methotrexate – insights into oral adverse events

Cell number per unit Control 1 nM MTX-concentration
10 nM 10 nM 10 nM
Day 1 mean 13.50 17.83 28.67 25.50 33.17
  SD 4.76 5.74 13.55 9.01 7.49
  95% CI 10.48-16.52 11.81-23.86 14.45-42.88 16.05-34.95 25.30-41.03
Day 3 mean 37.58 54.02 74.01 65.83 85.17
  SD 15.72 19.22 18.24 9.04 12.07
  95% CI 27.59-47.57 33.84-74.16 54.86-93.14 56.34-75.32 72.50-97.84
Day 6 mean 159.92 110.67 69.33 63.67 70.50
  SD 47.86 15.85 19.63 7.23 10.21
  95% CI 129.51-190.33 94.04-127.30 48.73-89.94 56.08-71.25 59.78-81.22
Day 8 mean 222.04 97.51 59.83 56.17 63.67
  SD 40.72 18.08 23.09 12.70 12.31
  95% CI 192.13-247.87 78.53-116.47 35.60-84.07 42.84-69.50 50.75-76.58
Day 10 mean 221.17 68.00 31.17 33.53 36.33
  SD 51.30 30.68 7.71 16.79 6.22
  95% CI 188.57-253.76 35.80-100.20 23.08-39.25 15.88-51.12 29.81-42.86
Day 14 mean 210.92 90.83 41.17 37.83 40.83
  SD 55.25 49.06 8.09 16.52 11.48
  95% CI 175.82-246.02 39.34-142.34 32.68-49.65 20.49-55.17 28.79-52.88
  1. SD = standard deviation; 95% CI = 95% confidence interval.